| Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry GF Romiti, B Corica, M Proietti, DA Mei, J Frydenlund, A Bisson, G Boriani, ... EClinicalMedicine 63, 2023 | 6 | 2023 |
| Resultados de una estrategia de vigilancia con prueba de antígeno de SARS-CoV-2 J Benger, ME Esandi, V Viego, A Caccavo, AS Firpo, M Bru, J Funes, ... Medicina (Buenos Aires) 82 (3), 321-331, 2022 | | 2022 |
| Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry G Lip, A Kotalczyk, C Teutsch, HC Diener, S Dubner, J Halperin, CS Ma, ... Clinical Research in Cardiology 111 (5), 593-593, 2022 | | 2022 |
| Results of a surveillance strategy with SARS-CoV-2 antigen testing J Benger, ME Esandi, V Viego, A Caccavo, AS Firpo, M Bru, J Funes, ... Medicina 82 (3), 321-331, 2022 | | 2022 |
| Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ... The Lancet Diabetes & Endocrinology 10 (1), 35-45, 2022 | 39 | 2022 |
| Effect of colchicine vs usual care alone on intubation and 28-day mortality in patients hospitalized with COVID-19: a randomized clinical trial R Diaz, A Orlandini, N Castellana, A Caccavo, P Corral, G Corral, ... JAMA network open 4 (12), e2141328-e2141328, 2021 | 39 | 2021 |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 24 | 2021 |
| Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry G Ntaios, MV Huisman, HC Diener, JL Halperin, C Teutsch, S Marler, ... Hellenic journal of cardiology 62 (2), 152-157, 2021 | 3 | 2021 |
| Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... European journal of heart failure 22 (11), 2160-2171, 2020 | 57 | 2020 |
| Consenso Síndrome Coronario Agudos sin Elevación del Segmento ST-2020. Sociedad Argentina de Cardiología M Trivi, JP Costabel, M Spennatto, E Duronto, A Caccavo, V Mauro Rev Argent Cardiol 88, 1-61, 2020 | 8 | 2020 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 259 | 2019 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2369 | 2019 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 558 | 2019 |
| Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 198 | 2019 |
| Características de los pacientes mayores de 75 años en el Registro ARGEN-IAM-ST YBC COSTA, A Caccavo, AA Charask, K Moreno, C Cassano, ... Revista argentina de cardiología 87 (1), 41-50, 2019 | 10 | 2019 |
| Características clínicas, tratamiento y evolución de los pacientes adultos mayores de 75 años con infarto en Argentina. Datos del Registro ARGEN-IAM-ST Y Castillo Costa, A Caccavo, A Charask, K Moreno, C Cassano, ... Rev Argent Cardiol 87, 48-52, 2019 | 5 | 2019 |
| Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study P Langhorne, MJ O'Donnell, SL Chin, H Zhang, D Xavier, A Avezum, ... The Lancet 391 (10134), 2019-2027, 2018 | 139 | 2018 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 405 | 2018 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 945 | 2018 |
| QT prolongation and torsades de pointes: case report A Caccavo Reactions 1629, 82-26, 2016 | | 2016 |
